Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms by unknown
Brief Detlnitive  Report 
Transient Increase in Circulating y/8 T  Cells during 
Plasmodium  vivax Malarial Paroxysms 
By M. Kanthi Perera,* Richard Carter,~ Renu Goonewardene,* 
and Kamini N. Mendis* 
From the *Malaria Research Unit, Department of Parasitology, Faculty of Medicine, University 
of Colombo, Colombo 8, Sri Lanka; and the Ilnstitute of Cell, Animal and Population Biology, 
Division of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JT, Scotland 
Summary 
The percentage of peripheral blood mononuclear cells  (PBMC) bearing the CD3 § phenotype 
and the ot/~  and 3//8 T  cell receptors (TCR)  in PBMC were examined in Plasmodium vivax 
malaria patients and convalescents. The cells were labeled with monoclonal antibodies,  stained 
with either fluorescene or phycoerythrin, and examined by ultraviolet (UV) microscopy. A highly 
significant increase in both the proportion and the absolute numbers of 3//8 T  cells (p <0.005 
and <0.001, respectively, Student's t test) was observed in nonimmune P. vivax patients during 
clinical  paroxysms compared to nonmalarial controls. These T cells, which normally constitute 
not  more  than  3-5%  of PBMC,  constituted  ~<30% of PBMC  during  paroxysms  in  these 
nonimmune patients in whom the clinical  symptoms were severe. A less significant increase of 
3//8 T cells were also observed in these nonimmune patients during infection, between paroxysms 
and during convalescence.  In contrast, in an age-matched group of semi-immune patients resident 
in a malaria-endemic region of the country, in whom the clinical disease was comparatively mild, 
there was no increase in 3//8 T cells either during infection,  even during paroxysms, or convalescence. 
The severity of disease symptoms in patients as measured by a clinical  score correlated positively 
with the proportion of 3//8 T cells in peripheral blood (r =  0.53, p <0.01), the most significant 
correlation being found between the prevalence and severity of gastrointestinal symptoms, nausea, 
anorexia, and vomiting, and the proportion of 3//8 T cells (r =  0.49, p  =  0.002). These findings 
suggest that 3//8 T cells have a role to play in the pathogenesis of malaria, possibly in the general 
constitutional  disturbances  and particularly  in gastrointestinal  pathology in malaria. 
T  lymphocytes, which express the CD3 marker and lack 
CD4 and CD8 markers,  have been shown to lack ma- 
ture messenger (m)RNA for ot and/3 genes and express the 
y and 8 genes and proteins (1). Such lymphocytes expressing 
the TCR-3//6  constitute a minor subpopulation in the pe- 
ripheral blood of adults, and many of them reside in the spleen, 
and  to  a lesser extent  in  the  thymus,  tonsils  (2),  and  the 
epithelia of the large intestine (3) and lung (4). The biolog- 
ical role of the cells bearing the TCR-3,/8 is as yet unclear, 
but there are indications that some 3//8 T  cells can mediate 
cytotoxicity (4). 3'/8 T cells behave like c~/B T cells in that 
they secrete the lymphokines IL-2, IFN-y, TNF-o~ and ~3, 
and express cytotoxic activity (5-7). 
Recent evidence has led to speculation about an involve- 
ment of 3//8 T cells in immunity and/or immunopathology 
in human malaria.  The frequency of 3//8 T  cells in the pe- 
ripheral blood of acute Plasmodium  falciparum malaria-infected 
individuals has been shown to increase,  and remain elevated 
for several weeks during convalescence (8).  In nonimmune 
individuals, a vast majority of T cells vigorously proliferating 
in response to freeze-thawed extracts of P. falciparum blood 
stage parasites  in vitro have been shown to be 3//8 T  cells 
(9-11), and are the source of a significant fraction of TNF-a 
and IFN-3/that  were produced in these cultures  (12). 
There is much recent evidence to suggest that TNF and 
other cytokines are involved in the clinicopathological effects 
of malaria (13-17).  We have shown that  individuals living 
in malaria-endemic regions acquire a clinical (antidisease)  im- 
munity to malaria which is distinct from antiparasite immu- 
nity. In acute Plasmodium vivax malaria, patients among resi- 
dents  of malaria-endemic  regions  in  Sri  Lanka,  both  the 
intensity of the clinical disease and the underlying pathology 
were considerably less than  in nonimmune  individuals  ex- 
periencing  a primary infection (Karunaweera, N. D., R. Carter, 
G. E.  Grau,  and K.  N.  Mendis,  manuscript  submitted for 
publication). In this study we examined the lymphocyte com- 
position in the peripheral blood of acute P. vivax patients who 
were either clinically non- or semi-immune, and who reside 
in a malaria-nonendemic  and -endemic region, respectively, 
paying particular attention to paroxysms, the prominent peri- 
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malaria infection. We report here that profound changes occur 
in the composition of PBLs during a malaria infection in the 
nonimmune patient, particularly with respect to 7/(5 T cells 
which  normally constitute  an  insignificant  component  of 
PBLs. 
Materials and Methods 
Patients.  PBMC were studied in adult P. vivax patients (a) during 
the course of an acute  infection soon after  diagnosis  and before 
antimalarials  were administered;  and (b) during convalescence 4-6 
wk after a P. vivax infection was drug treated.  Patients  and con- 
valescents were studied  from two groups viz: (a) residents  of the 
malaria-nonendemic area of Sri Lanka (Colombo and its suburbs) 
(18) who had acquired  the infection on a visit  to an endemic re- 
gion, many of whom had not experienced  a malaria infection pre- 
viously (see Table 1); and (b) residents  of Kataragama,  a P. vivax 
malaria-endemic  region in southern Sri Lanka (19), who had expe- 
rienced many previous infections of  malaria. In both groups of  acute 
P. vivax patients, cells were examined either at or between paroxysms. 
Paroxysms are periodic clinical events that coincide with schizont 
rupture and that are characterized by a sharp rise and fall of body 
temperature accompanied by chills, rigors, and sweating,  in that 
order (16). In most endemic patients,  the paroxysms were not as 
clinically pronounced as in the nonendemic patients,  and in both 
groups of patients,  the time of schizont rupture as monitored on 
a Giemsa-stained  blood film  served as a guide to the onset of a 
paroxysm. An age-matched group of healthy individual  Colombo 
residents  who had no past  history of malaria,  were  studied  as 
controls. 
In all subjects, a malaria diagnosis was made by microscopic ex- 
amination of a blood film. A complete history was taken,  and in 
the case of patients (but not convalescents)  the clinical state was 
evaluated by the use of a questionnaire (Clinical Evaluation Form 
CL1.90) which has been developed and validated by us and described 
previously (Karunaweera,  N.  D.,  R.  Carter,  G.  E.  Grau,  and 
K. N. Mendis, manuscript submitted for publication).  Briefly, the 
prevalence and degree of severity of each of 11 symptoms (head- 
ache,  myalgia,  arthralgia,  shivering,  cold,  sweating,  nausea, 
vomiting, anorexia,  backache,  and hypochondrial pain)  were de- 
termined as perceived by the patient and assigned a score ranging 
from 0 to 3 if it was absent,  mild, moderate,  or severe, respectively. 
Thereafter,  a total clinical score was derived for every patient, this 
being the sum of the scores of the individual  symptoms. The clin- 
ical assessment  was introduced when the study was in progress, 
therefore clinical scores are available only for a proportion of patients. 
Preparation, Staining, and Analysis of  PBMC.  After voluntary in- 
formed consent, patients  were bled by venepuncture into heparin 
(10 U/ml) and PBMC were isolated using Lymphoprep  TM (Nycomed 
AS, Oslo, Norway) as previously described (20). Total mononuclear 
cell counts were made in a hemocytometer and washed cells were 
resuspended  in PBS, with 0.1%  sodium azide and 2% FCS at a 
concentration of 2  x  107 cells/ml;  aliquots containing 106 cells, 
each stained with mAbs directed against Leu-4 (anti-CD3), Leu-3 
(anti-CD4), and Leu-2 (anti-CD8), all fluorescein conjugated; and 
TCR-3~/8,  which was PE conjugated (Becton Dickinson & Co., 
Mountain View, CA) using standard  methodology (11). Aliquots 
of stained cells were each resuspended in 20 #1 of  mounting medium 
(PBS containing 0.1% sodium azide and 50% glycerol) and 10/xl 
was placed  under  a 22  x  22-mm coverslip  and  examined  at  a 
magnification  of  400 on a Leitz Ortholux fluorescence microscope. 
A minimum of  360 stained cells or 15 microscope fields (whichever 
was lower)  was examined.  Analysis of stained  cells from five pa- 
tients using a FACS  |  (Becton Dickinson & Co.), confirmed that 
results  of direct  microscopy by eye was equally  reliable. 
Results 
Individuals in the three study groups were comparable in 
age, but differed markedly with respect to their past malaria 
experience (Table  1).  Patients  and convalescents from Kata- 
Table  1.  Desc@tion of Test and Control Groups* 
Control~  Nonendemic  Endemic  g  value~ 
Number of subjects  8  25  42 
Age range in years  (median)  22-42 (37)  16-65 (28)  14-56 (28)  NS 
Previous malaria  infections 
Range (median)  0  0-1  (0)  2-20 (10)  <0.001 
Percent parasitaemia f~ 
Range  NA  0.004-0.57  0.001-0.34  <0.01 
Mean (_+  SD)  0.14  (_+0.14)  0.044 (_+  0.073) 
Clinical  score I 
Score range  (mean)  NA  14-33 (20.88)  6-25  (13.5)  <0.005 
* Test groups include patients (during and between paroxysm) and convalescents. 
* Nonmalarial controls. 
S Significance of difference between endemic and nonendemic subjects (Students t test) (during infection and paroxysm) is given here. 
II Parasitaemias of patients only, excluding convalescents, are given here (n  =  18 in nonendemics; n =  24 in endemics). Mean =  arithmatic mean. 
I The clinical scores (given in points) were available only in 13 nonendemic and 33 endemic patients. Mean  =  geometric mean. 
NA, not applicable; NS (p >0.05). 
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malaria infections, had significantly lower parasite densities 
in blood, and experienced less intense clinical symptoms as 
indicated by their lower clinical score than did nonendemic 
patients, a majority of whom had no previous experience of 
malaria at all (Table 1). Endemic patients thus showed evi- 
dence of both an antiparasite and a clinical or antidisease im- 
munity. 
An analysis  of the cell types among PBMC  revealed  a 
significant increase in the proportion of 3,/5 T cells in nonim- 
mune patients during clinical paroxysms. These cells, which 
normally represent not more than 3-5% of PBMC, constituted 
up to 26%  of the circulating mononuclear cell population 
during a paroxysm in nonimmune patients (Fig. 1). A moder- 
ate but less significant increase in the proportion of 3,/5 T 
cells was also observed during infection (between paroxysmal 
events) and convalescence in these nonimmune patients com- 
pared to nonmalarial controls (Fig.  1). In none of the en- 
demic patients, however, was there a significant elevation of 
the proportion of 3'/~ T cells beyond the levels which prevailed 
in nonmalarial controls either during infection (at or between 
paroxysms) or convalescence. Thus, the proportion of 3,/5 
T  ceils in the nonimmune patients during paroxysms was 
significantly higher than  that  of the endemics at  a corre- 
sponding time of the infection (p <0.005,  Student's t test) 
or of any other category of individuals studied,  including 
nonmalarial controls. 
The absolute ~//5 cell counts of the nonimmune patients 
were also significantly elevated during a paroxysm compared 
to those of normal controls (p <0.001). This was so, despite 
a significant reduction in the total mononuclear cell counts 
which occurred in all patients, particularly during a paroxysm 
(Table 2). The difference in the absolute 3,/5 cell counts be- 
tween  nonendemic and  endemic patients  at  the  time  of 
paroxysms was thus as significant as the difference between 
their proportions  (p <0.005;  Table 2). 
In the patients (both endemic and nonendemic) in whom 
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Figure  1.  The percentage of 3'/~5 T ceils (O) among PBMC in acute 
malaria patients from a malaria-nonendemic, and an endemic region during 
and between paroxysms, in comparison with those in nonmalarial con- 
trols from the nonendemic region.  (  ) Arithmetic mean. 
measure of disease severity) correlated positively with the per- 
cent proportion ofqr/5 T ceils in peripheral blood (r =  0.53, 
Spearman Rank  Correlation, p  <0.01;  Fig.  2).  When in- 
dividual symptoms were analyzed, the highest correlation with 
the proportion of 3,/5 cells was obtained with symptoms 
relating to the gastrointestinal tract, namely, anorexia, nausea, 
and vomiting, each of which gave a significant correlation 
on their own with "//5 T  cells, as well as when they were 
combined (r  =  0.49 and p  =  0.002),  the best correlation 
having been obtained with the prevalence of vomiting (p  = 
0.007).  Even when these three symptoms were removed from 
Table  2.  Absolute Cell Counts of Test and Control Groups* 
Geometric mean (x/+ SD)  of cell counts//~l in 
Nonendemic  Endemic 
Cell type  Controls  Paroxysm  Infection  Convalescence  Paroxysm  Infection  Convalescence 
Mononuclear  1,210  1,053  1,237  1,601  806  946  1,796 
(x/+0.21)  (x/+0.23)  (x/+0.13)  (x/+0.15)  (x/+0.14)  (x/+0.20)  (x/+0.15) 
3"/c5  18.33  110.3  46.3  61.26  10.57  9.07  42.29 
(x/ + 0.52)  (x/ + 0.28)  (x/ + 0.36)  (x/ + 0.43)  (x/ + 0.67)  (x/ + 0.7)  (x/ + 0.78) 
The difference between the absolute total mononuclear cell counts of nonendemic patients  (during infection and paroxysms) and endemic patients 
was  significant (p <0.05). 
The difference between the absolute 3,/(5 T  cell counts of nonendemic and endemic patients  at paroxysm  was highly significant (p <0.005). 
* Test groups  include patients  (during and between paroxysm)  and convalescence. 
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Fig"re  2.  The relationship between  the severity  of clinical disease (clin- 
ical score) and the percentage of ?/6 T cells among PBMC during infec- 
tion in patients from the malaria-nonendemic and -endemic regions. In 
some patients, the cell counts were made during a paroxysm, n = 12 (I), 
and in others during infection  between  paroxysms, n = 25 (O). The single 
regression line applies to all values; r = 0.53 and p = <0.01 (Spearman 
Rank Correlation). 
the total score,  the correlation with the proportion  of 3"/8 
T  cells was still evident, though less significant (r  =  0.377 
and p  =  0.023). 
The differences in the absolute 3"/8 T cell counts and clin- 
ical scores of patients between the non- and semi-immunes 
were not due to differences in the parasite density between 
the two groups. Multiple linear regression analyses in which 
the degree of parasitaemia  was controlled,  revealed  that  at 
any given parasite density, the 3"/8 cell count would be 74 
cells//xl higher (p =  0.0025), and the clinical score six points 
higher (p  =  0.0072) in the nonendemic than in the endemic 
patients. 
Double staining of cells confirmed that cells which stained 
with 3,/6 markers were CD3 positive and negative with ot/B 
markers. Consequently, nonimmune patients at paroxysm in 
whom the greatest increase in 3"/8 T cells occurred, recorded 
the lowest proportion  of c~/fl T  cells  (data not  shown). 
Discussion 
A significant increase in both the proportion and absolute 
numbers  of 3"/8 T  cells was observed in the circulation  of 
nonimmune  patients  during a paroxysm.  This increase ap- 
pears to be transient,  because at no other stage of infection 
or  convalescence  were  these  cells  detected  in  such  large 
numbers. Equally striking was the complete absence of such 
an increase in the immune patient even during a paroxysm. 
A previous study (8) demonstrated an increase in the number 
and proportion  of 3,/6 T  cells  during  the course of P. fib 
ciparum infections, though the data was not given in relation 
to the stage of the parasite's  development in the erythrocytic 
cycle as presented here. We demonstrate here that in P. vivax 
infections, both the proportion and the absolute numbers of 
3"/6 T cells increase,  and that this increase is associated with 
the time of schizont rupture and the event of a paroxysm. 
We have previously described several other transient  events 
in the circulation of nonimmune  patients  during the event 
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of a paroxysm which are evoked by the rupture of schizont- 
infected erythrocytes.  One,  was a sharp but transient  rise, 
and then fall of circulating plasma TNF-c~ levels in close par- 
allel to the rise and fall of body temperature that occurs during 
a paroxysm (16). The other, was the detection of a transient 
parasite-inactivating  activity in the plasma during the peak 
of a paroxysm. This activity was dependent on both plasma 
TNF and an as yet unidentified  plasma factor(s),  the pres- 
ence in plasma of which is very transient  (15). The malarial 
paroxysm is therefore an event marked by several pronounced 
and transient changes in the circulation of the nonimmune 
patients.  In the immune patients,  not only is the intensity 
of the paroxysms less, but the accompanying changes,  in- 
cluding the rise in plasma TNF, the parasite-inactivating  effects, 
and as reported here,  the increase  in circulating 3"/8 T cells, 
are much less apparent  (15). 
At least two independent observations made in this study 
suggest that 3"/6 T cells could play a role in the pathogenesis 
of malaria.  The first, is the pronounced and transient increase 
in T/8 T cells in the circulation of clinically nonimmune pa- 
tients during paroxysms, and the absence of this phenomenon 
in the clinically immune patients in whom the disease runs 
a milder course and in whom paroxysms are distinctly less 
intense.  The second is the significant  correlation between the 
proportion of 3'/8 T cells in peripheral blood and the inten- 
sity of clinical  disease in patients in general.  The incidence 
of 3'/5 cells in the peripheral circulation correlated best with 
the prevalence and intensity of gastrointestinal  symptoms, 
which viewed in the light of their normal residence in intes- 
tinal epithelium suggest that their activity may be linked to 
intestinal pathology in malaria.  The transient increase in 3"/8 
T  cells in the circulation is likely to be the result of recruit- 
ment of cells into the circulation from tissue sources in re- 
sponse to parasite  exo-antigens  which  are  released  during 
schizont rupture in vivo. These cells may be a source of the 
cytokines that are transiently and markedly elevated during 
a paroxysm in the nonimmune patient. Alternatively, cytokines 
produced during a paroxysm might themselves provide the 
stimulus for the recruitment  of 3"/8 T  cells from their  se- 
questered sites  into  the circulation. 
These findings support the view that 3"/5 T cells may be 
involved in the pathogenesis of malaria (12),  at least in the 
constitutional  disturbances such as paroxysms and possibly 
in symptoms that relate to gastrointestinal disturbances that 
accompany the disease  in  acute uncomplicated  malaria. 
Endemic patients in whom the disease was much less in- 
tense were characterized  not only by the absence of an in- 
crease in 3"/6 T cells, but also by a general lymphopenia which 
was more pronounced than in the nonendemic patients. We 
have previously suggested that one of the mechanisms of ac- 
quiring clinical  immunity was by downregulating  cells in- 
volved in pathogenesis (20, Karunaweera, N. D., P. Gamage, 
R. Carter, K. N. Mendis., manuscript submitted for publi- 
cation). An understanding of how this cellular downregula- 
tion  is brought  about  in  endemic patients  without  com- 
promising antiparasite immunity which also develops with 
increasing exposure to malaria might provide an important 
clue to malarial  immunity. 
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